Bacteria found in the bladders of healthy women differ from bacteria in women with a common form of incontinence, according to researchers from Loyola University Chicago Stritch School of Medicine. These findings, published July 9, 2014, in the American Society for Microbiology's online journal mBio, suggest that bacterial communities may play a role in female urinary health.
"Urgency urinary incontinence (UUI) is a common, yet poorly understood, condition with symptoms similar to urinary tract infections," says Alan Wolfe, PhD, co-investigator and professor of Microbiology and Immunology. "If we can determine that certain bacteria cause UUI symptoms, we may be able to better identify those at risk for this condition and more effectively treat them."
Approximately 15 percent of women suffer from UUI and yet an estimated 40 percent to 50 percent do not respond to conventional treatments. One possible explanation for the lack of response to medication may be the bacteria present in these women.
This study evaluated urine specimens of 90 women with and without UUI symptoms. Samples were collected through a catheter and analyzed using an expanded quantitative urine culture (EQUC) technique. This technique was able to find bacteria that are not identified by the standard culture techniques typically used to diagnose urinary tract syndromes. This study also used 16S rDNA sequencing to classify bacterial DNA. The UUI and non-UUI urinary bacteria differed by group based on both culture type and sequence.
"These findings may have strong implications for the prevention, diagnosis and treatment of women with this form of incontinence," says Paul Schreckenberger, PhD, co-investigator and director of the clinical microbiology laboratory at Loyola University Health System.
Source: Loyola University Health System
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.